Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs) (Protocol)

Vanessa Glennon, Samuel L. Whittle, Catherine L. Hill, Renea V. Johnston, Jodie C. Avery, Liesl Grobler, Bayden J. McKenzie, Sheila Cyril, Jordi Pardo Pardo, Rachelle Buchbinder

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)


Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. The primary objective is to assess the benefits and harms of short-term glucocorticoid therapy (six months or less) compared to placebo, for adults with rheumatoid arthritis who experience a disease flare while receiving standard disease-modifying anti-rheumatic drug (DMARD) therapy. The secondary objective is to maintain the currency of the evidence, using a living systematic review approach.

Original languageEnglish
Article numberCD014898
Number of pages16
JournalCochrane Database of Systematic Reviews
Issue number11
Publication statusPublished - 16 Nov 2021

Cite this